Black Rock Inc. Lineage Cell Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,559,466 shares of LCTX stock, worth $6.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,559,466

Previous 8,494,395 12.54%

Holding current value

$6.5 Million

Previous $12.6 Million 23.96%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.89 - $1.47 $947,913 - $1.57 Million	1,065,071 Added 12.54%	9,559,466 $9.56 Million
Q1 2024 May 10, 2024	SELL	$0.86 - $1.48 $31,908 - $54,912	-37,103 Reduced 0.43%	8,494,395 $12.6 Million
Q4 2023 Feb 13, 2024	SELL	$0.91 - $1.35 $688,447 - $1.02 Million	-756,536 Reduced 8.15%	8,531,498 $9.3 Million
Q3 2023 Nov 13, 2023	BUY	$1.16 - $1.53 $320,125 - $422,234	275,970 Added 3.06%	9,288,034 $11 Million
Q2 2023 Aug 11, 2023	BUY	$1.26 - $1.53 $6.68 Million - $8.11 Million	5,302,486 Added 142.94%	9,012,064 $12.7 Million
Q1 2023 May 12, 2023	SELL	$1.2 - $1.53 $89,080 - $113,578	-74,234 Reduced 1.96%	3,709,578 $5.56 Million
Q4 2022 Feb 13, 2023	BUY	$1.02 - $1.5 $81,013 - $119,137	79,425 Added 2.14%	3,783,812 $4.43 Million
Q3 2022 Nov 14, 2022	SELL	$1.13 - $1.77 $58,048 - $90,924	-51,370 Reduced 1.37%	3,704,387 $4.19 Million
Q2 2022 Aug 12, 2022	SELL	$1.12 - $1.61 $6.78 Million - $9.75 Million	-6,053,366 Reduced 61.71%	3,755,757 $5.93 Million
Q1 2022 May 12, 2022	SELL	$1.21 - $2.48 $241,258 - $494,479	-199,387 Reduced 1.99%	9,809,123 $15.1 Million
Q4 2021 Feb 10, 2022	BUY	$1.84 - $2.68 $2.68 Million - $3.9 Million	1,456,810 Added 17.04%	10,008,510 $24.5 Million
Q3 2021 Nov 09, 2021	BUY	$2.26 - $2.86 $27,504 - $34,806	12,170 Added 0.14%	8,551,700 $21.6 Million
Q2 2021 Aug 11, 2021	BUY	$2.17 - $3.0 $18.5 Million - $25.6 Million	8,539,530 New	8,539,530 $24.3 Million

Others Institutions Holding LCTX

# of Institutions

134

Shares Held

106M

Call Options Held

22.1K

Put Options Held

View Full List

About Lineage Cell Therapeutics, Inc.

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $115M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

More about LCTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account